Submitted Successfully!
To reward your contribution, here is a gift for you: A free trial for our video production service.
Thank you for your contribution! You can also upload a video entry or images related to this topic.
Version Summary Created by Modification Content Size Created at Operation
1 + 1237 word(s) 1237 2021-04-08 06:06:01 |
2 update layout and reference Meta information modification 1237 2021-04-16 05:57:29 | |
3 Roll back entry to make some changes. Meta information modification 1237 2021-04-20 06:07:20 | |
4 move out from EC Meta information modification 1237 2021-09-22 04:39:46 |

Video Upload Options

Do you have a full video?

Confirm

Are you sure to Delete?
Cite
If you have any further questions, please contact Encyclopedia Editorial Office.
Cazzato, G. Pleomorphic Hyalinizing Angiectatic Tumor. Encyclopedia. Available online: https://encyclopedia.pub/entry/8724 (accessed on 28 March 2024).
Cazzato G. Pleomorphic Hyalinizing Angiectatic Tumor. Encyclopedia. Available at: https://encyclopedia.pub/entry/8724. Accessed March 28, 2024.
Cazzato, Gerardo. "Pleomorphic Hyalinizing Angiectatic Tumor" Encyclopedia, https://encyclopedia.pub/entry/8724 (accessed March 28, 2024).
Cazzato, G. (2021, April 15). Pleomorphic Hyalinizing Angiectatic Tumor. In Encyclopedia. https://encyclopedia.pub/entry/8724
Cazzato, Gerardo. "Pleomorphic Hyalinizing Angiectatic Tumor." Encyclopedia. Web. 15 April, 2021.
Pleomorphic Hyalinizing Angiectatic Tumor
Edit

Pleomorphic hyalinizing angiectatic tumor (PHAT) is a very rare entity of soft tissue considered a “neoplasm of uncertain behaviour of connective or other soft tissue” by the World Health Organization (2020).

soft tissue PHAT immunohistochemistry

1. Introduction

Pleomorphic hyalinizing angiectatic tumor (PHAT) is a very rare entity of soft tissue, first described in 1996 by Smith et al. in a series of 14 cases as a “low-grade sarcoma of uncertain lineage” [1]. In “Soft Tissue and Bone Tumours” by the World Health Organization 2020, PHAT is considered a “neoplasm of uncertain behavior of connective or other soft tissue” [2] and is defined as “very rare” with, to our knowledge, about 100 cases reported in the international literature. PHAT affects patients from 10 to 79 years of age, with slight female predilection [3][4], and it develops in subcutaneous tissue of the lower extremities, more frequently in the region of the ankle and foot [4], and rarely as a deep-seated soft tissue mass in locations as perineum, buttock, arms, head and neck, and viscera [5]. Although inconsistent cytogenetic data have been reported [2] in PHAT so far, there are potential morphological and genetic overlaps with hemosiderotic fibrolipomatous tumor (HFLT) and myxoinflammatory fibroblastic sarcoma (MIFS) [2][4]. However, the link between these cancers remains controversial and not fully understood [2][3].

2. Case Report

A 48-year-old woman was referred to the U.O.C. of Plastic Surgery for a volumetric increase in a mass at the level of the right thigh, present for about 15 years and which in recent months had begun to cause functional discomfort. An echography (US) had confirmed the presence of an intensely vascularized subcutaneous lesion and in agreement with the patient it was decided to opt for the surgical option. The patient underwent a wide surgical excision with histologically confirmed margins free from neoplasm.

The sample had therefore been sent to our laboratory and it appeared as a lesion of 6 × 5.5 × 5 cm, with a multiple chambered and collated appearance when cut and a greyish color (Figure 1).

Figure 1. Collated appearance when cut and a greyish color.

After sampling, processing, inclusion in paraffin and microtome cutting, 5-micron thick sections were prepared and stained with routine staining (Hematoxylin-Eosin) and other sections were prepared by immunostaining with anti-CD34, Desmin, Vimentin, Actin Smooth muscle, Ki67 (MIB1), and S-100 protein.

Microscopically, the lesion was composted of clusters of variably sized, thin walled, ectatic blood vessels scattered and surrounded by a thick rim of amorphous eosinophilic material, with fibrosis (Figure 2A,B). There were also organizing thrombi within blood vessels and the tumour cells were arranged in fascicles or, less frequently, sheets with spindle morphology (Figure 2C), sometimes hemosiderin pigment, and nuclear pseudo inclusions. At the periphery, the lesion showed a pseudo infiltrative pattern of growth. There were not cytological atypia and mitotic figures. From the immunohistochemical point of view, we found that the lesion was positive for CD34 (Figure 2D) and Vimentin, while it was negative for Desmin, S-100 protein and smooth muscle actin. The fraction of neoplastic proliferation (valued by KI67) was <5%.

Figure 2. (AC): The neoplasia was composted of clusters of variably sized, thin walled, ectatic blood vessels scattered and surrounded by a thick rim of amorphous eosinophilic material, with fibrosis phenomena. The lesion was positive for CD34 (D).

After a second opinion consultation with a soft tissue expert pathologist, PHAT diagnosis was placed. At the follow-ups of 6 months and 12 months, the patient showed no local recurrence.

3. Discussion

Pleomorphic hyalinizing angiectatic tumors was firstly described in 1996 by Smith et al. [1] and, to date, about 100 cases have been reported in literature [6]. Table 1 details authors, year of publication of the case series/case report, gender, age, and location of the PHAT.

Table 1. Case of PHAT reported in International Literature.

The mean age at diagnosis was 54.5 ± 17.1 (range 10–89). Of the patients, 61% (60/102) were female. The most common location was the lower extremity in 77.3% (78/102) of the cases, but other localizations were possible such as perineum, buttock, arms, head and neck, and viscera [5]. The average dimensions were around 5.3 cm, with an exceptional case of 26.3 cm in male breast reported by Lee et al. in 2005 [16]. Interestingly, Wei et al. [26] and Chalmeti et al. [35] reported two cases of PHAT respectively at the level of the renal hilum and within the kidney itself, emphasizing the potential problem of confusing this entity with other neoplasms of kidney. Our data completely agrees with Rush et al. [41], who in a recent article in 2018 conducted a detailed review of the literature more focused on the surgical-oncological implications related to PHAT. The best therapeutic strategist is represented by large surgery with free margins [26][41]. The recurrence rate is around 30–40% of cases [2][26][41] when it is not possible to be surgically radical, and local relapses have been described [41], although distant metastases have never been reported [2][41]. Local radiotherapy has also been shown to reduce the rate of local recurrence [26][28][41].

In most of cases it has a lobulated appearance, with a gray to light brown cut surface. It is never encapsulated, and many of these lesions have diffusely infiltrative edges, although well-defined margins [7][8][9][10][11][12][13][14][15][16][17][18][19][20][21][22][23][24][25][26][27][28][29][30][31][32][33][34][35][36][37][38][39][40][41]. Sometimes, PHAT can have a prominent cystic component [16][17][18][19]. From a histological point of view, PHAT is composed of clusters of ectatic blood vessels, surrounded by a thick rim of amorphous eosinophilic material, often with associated fibrosis. Immunohistochemically, PHAT is strongly positive for CD34, sometimes CD99 and negative for S-100 protein, Actin, Desmin, Cytokeratin, CD31, Factor VIII and Epithelial membrane antigen (EMA). Groisman et al. [9] reported immunoreactivity for vascular endothelial growth factor (VEGF), but this marker was negative in our case.

The morphological features of PHAT raised a wide range of differential diagnosis such as neurofibroma, schwannoma with ancient aspects, and undifferentiated pleomorphic sarcoma [7][11]. Although neurofibroma may show CD34 positivity, this entity is positive for S-100 protein and EMA, and the absence of cluster ectatic hyalinized vessel allows for a correct differential diagnosis. Unlike the ancient schwannoma, PHAT is encapsulated and it lacks Antoni A and B zones, as well as being negative for S-100 protein [5][6][7]. Finally, low mitotic count, lack of CD34 expression, tumor necrosis and intranuclear cytoplasmic pseudoinclusion can immediately exclude undifferentiated pleomorphic sarcoma [6][11][12][13][14].

References

  1. Smith, M.E.F.; Fisher, C.; Weiss, S.W. Pleomorphic hyalinizing angiectatic tumor of soft parts: A low-grade neoplasm resembling neurilemoma. Am. J. Surg. Pathol. 1996, 20, 21–29.
  2. Soft Tissue and Bone Tumours. WHO Classification of Tumours, 5th ed.; World Health Organization: Geneva, Switzerland, 2020; Volume 3.
  3. Changchien, Y.C.; Bocskai, P.; Kovács, I.; Hargitai, Z.; Kollár, S.; Török, M. Pleomorphic hyalinizing angiectatic tumor of soft parts: Case report with unusual ganglion-like cells and review of the literature. Pathol. Res. Pract. 2014, 210, 1146–1151.
  4. Choong, M.Y.; Ke, P.Z.; Huang, C.Y.; Li, T. Pleomorphic hyalinizing angiectatic tumor in the inguinal area: A potential diagnostic pitfall. Am. Surg. 2012, 78, E45–E46.
  5. Peng, H.C.; Huang, M.T.; Chen, D.J.; Leung, T.K.; Chu, J.S. Pleomorphic hyalinizing angiectatic tumor of soft parts. J. Formos. Med. Assoc. 2010, 109, 616–620.
  6. Fukunaga, M.; Ushigome, S. Pleomorphic hyalinizing angiectatic tumor of soft parts. Pathol. Int. 1997, 47, 784–788.
  7. Silverman, J.S.; Dana, M.M. Pleomorphic hyalinizing angiectatic tumor of soft parts: Immunohistochemical case study shows cellular composition by CD34+ fibroblasts and factor XIIIa+ dendrophages. J. Cutan. Pathol. 1997, 24, 377–383.
  8. Gallo, C.; Murer, B.; Roncaroli, F. Pleomorphic hyalinizing angiectasic soft-tissue tumor: Description of a case. Pathologica 1997, 89, 531–535.
  9. Groisman, G.M.; Bejar, J.; Amar, M.; Ben-Izhak, O. Pleomorphic hyalinizing angiectatic tumor of soft parts: Immunohistochemical study including the expression of vascular endothelial growth factor. Arch. Pathol. Lab. Med. 2000, 124, 423–426.
  10. Matsumoto, K.; Yamamoto, T. Pleomorphic hyalinizing angi-ectatic tumor of soft parts: A case report and literature review. Pathol. Int. 2002, 52, 664–668.
  11. Iwamoto, C.A.; Garcia, C.F.; Fung, C.; Razzak, M. A 49-year-old woman with a left axillary mass. Arch. Pathol. Lab. Med. 2003, 127, E107–E108.
  12. Folpe, A.L.; Weiss, S.W. Pleomorphic hyalinizing angiectatic tumor: Analysis of 41 cases supporting evolution from a distinctive precursor lesion. Am. J. Surg. Pathol. 2004, 28, 1417–1425.
  13. Fujiwara, M.; Yuba, Y.; Wada, A.; Ozawa, T.; Tanaka, T. Pleomorphic hyalinizing angiectatic tumor of soft parts: Report of a case and review of the literature. J. Dermatol. 2004, 31, 419–423.
  14. Lee, J.C.; Jiang, X.Y.; Karpinski, R.H.; Moore, E.D. Pleomorphic hyalinizing angiectatic tumor of soft parts. Surgery 2004, 137, 119–121.
  15. Luzar, B.; Gasljevic, G.; Juricic, V.; Bracko, M. Hemosiderotic fibrohistiocytic lipomatous lesion: Early pleomorphic hyalinizing angiectatic tumor? Pathol. Int. 2006, 56, 283–286.
  16. Capovilla, M.; Birembaut, P.; Cucherousset, J.; Ploton, D.; de Saint-Maur, P.P.; Flejou, J.F.; Lesec, G. Pleomorphic hyalinizing angiectatic tumor of soft parts: Ultrastructural analysis of a case with original features. Ultrastruct. Pathol. 2006, 10, 59–64.
  17. El-Tal, A.E.; Mehregan, D. Pleomorphic hyalinizing angiectatic tumor of soft parts: Case report and literature review. J. Cutan Pathol. 2006, 33, 361–364.
  18. Kazakov, D.V.; Pavlovsky, M.; Mukensnabl, P.; Michal, M. Pleomorphic hyalinizing angiectatic tumor with a sarcomatous component recurring as high-grade myxofibrosarcoma. Pathol. Int. 2007, 57, 281–284.
  19. Ke, Q.; Erbolat Zhang, H.Y.; Bu, H.; Li, S.; Shi, D.N.; Yang, G.H.; Chen, H.J.; Wei, B. Clinicopathologic features of pleomorphic hyalinizing angiectatic tumor of soft parts. Chin. Med. J. 2007, 120, 876–881.
  20. Jaggon, J.R.; Aitken, R.D. Pleomorphic hyalinizing angiectatic tumour of soft parts: A case report and review of the literature. West Indian Med. 2007, 56, 544–546.
  21. Tallarigo, F.; Squillaci, S.; Putrino, I.; Zizzi, N.; Bisceglia, M. Pleomorphic hyalinizing angiectatic tumor of the male breast: A heretofore unreported occurrence. Pathol. Res. Pract. 2009, 205, 69–73.
  22. Cimino-Mathews, A.; Ali, S.Z. Pleomorphic hyalinizing angi-ectatic tumor: Cytomorphologic features on fine-needle aspiration. Diagn. Cytopathol. 2011, 39, 214–217.
  23. Parameshwarappa, S.; Rodrigues, G.; Nagpal, N.; Rao, L. Pleomorphic hyalinizing angiectatic tumor of soft parts involving the upper limb. Indian J. Surg. 2010, 72, 263–264.
  24. Illueca, C.; Machado, I.; Cruz, J.; Almenar, S.; Noguera, R.; Navarro, S.; Llombart-Bosch, A. Pleomorphic hyalinizing angiectatic tumor: A report of 3 new cases, 1 with sarcomatous myxofibro- sarcoma component and another with unreported soft tissue palpebral location. Appl. Immunohistochem. Mol. Morphol. 2012, 20, 96–101.
  25. Subhawong, T.K.; Subhawong, A.P.; Montgomery, E.A.; Fayad, L.M. Pleomorphic hyalinizing angiectatic tumor: Imaging findings. Skeletal. Radiol. 2012, 41, 1621–1626.
  26. Wei, S.; Pan, Z.; Siegal, G.P.; Winokur, T.S.; Carroll, A.J.; Jhala, D. Complex analysis of a recurrent pleomorphic hyalinizing angiectatic tumor of soft parts. Hum. Pathol. 2012, 43, 121–126.
  27. Idrees, M.T.; Kieffer, T.; Badve, S. Pleomorphic hyalinizing angiectatic tumor of renal hilum. Ann. Diagn. Pathol. 2012, 16, 489–493.
  28. Rekhi, B.; Aggarwal, S. Pleomorphic hyalinizing angiectatic tumor exhibiting intricate branching vasculature: An interesting pattern in a rare tumor. Indian J. Pathol. Microbiol. 2013, 56, 321–323.
  29. Kuang, P. CT findings of pleomorphic hyalinizing angiectatic tumor (PHAT) of soft parts of the neck. Jpn. J. Radiol. 2013, 31, 204–207.
  30. Felton, S.J.; Ramlogan, D. Spontaneous bruising overlying a subcutaneous swelling: Pleomorphic hyalinizing angiectatic tumor, a relatively new entity of intermediate malignancy. Int. J. Dermatol. 2015, 54, 204–206.
  31. Morency, E.; Laskin, W.; Lin, X. Cytologic and histologic features of pleomorphic undifferentiated sarcoma arising in a hybrid hemosiderotic fibrolipomatous tumor and pleomorphic hyalinizing angiectatic tumor: Report of an unusual case with a literature review. Acta Cytol. 2015, 59, 493–497.
  32. Brazio, P.S.; Morrison, A.L.; Oh, M.; Goldberg, N.; Boutros, C.N. Large pleomorphic hyalinizing angiectatic tumor of the forearm: A multidisciplinary perspective. Surgery 2016, 159, 1471–1473.
  33. Kane, P.M.; Gaspar, M.P.; Whiting, B.B.; Culp, R.W. Pleomorphic Hyalinizing Angiectatic Tumor Arising in the Hand: A Case Report. Hand 2016, 11, NP20–NP23.
  34. Chu, Z.G.; Liu, M.Q.; Zhu, Z.Y.; Lv, F.J.; Ouyang, Y. Pelvic retroperitoneal pleomorphic hyalinizing angiectatic tumor (PHAT) of soft tissue: A case report. BMC Med. Imaging 2016, 16, 28.
  35. Chalmeti, A.; Arakeri, S.U.; Javalgi, A.P.; Goyal, S. Pleomorphic Hyalinizing Angiectatic Tumour: A Rare Case Report and Discussion of Differential Diagnosis. J. Clin. Diagn. Res. 2017, 11, ED15–ED16.
  36. Scalici Gesolfo, C.; Serretta, V.; Di Maida, F.; Giannone, G.; Barresi, E.; Franco, V.; Montironi, R. Clinical implications of a rare renal entity: Pleomorphic Hyalinizing Angiectatic Tumor (PHAT). Pathol. Res. Pract. 2017, 213, 165–169.
  37. Jaramillo, C.J.; Wojcik, J.; Weber, K.; Sebro, R. Imaging and histological appearance of pleomorphic hyalinizing angiectatic tumors: A case series and literature review. Oncol. Lett. 2018, 15, 4720–4730.
  38. Szep, Z.; Majernikova, A.; Rychly, B.; Majtan, J. Pleomorphic hyalinizing angiectatic tumor of soft parts with unusual lipoma-like clinical morphology. Indian J. Dermatol. Venereol. Leprol. 2018, 84, 619–621.
  39. Balasubiramaniyan, V.; Muduly, D.; Samal, S.; Kar, M.; Sultania, M.; Patra, S.; Das, P.K. Pleomorphic hyalinizing angiectatic tumor of the mesorectum: A rare case and review of literature. Autops. Case Rep. 2019, 9, e2019097.
  40. Kökoğlu, K.; Gülmez, E.; Çağlı, S.; Yüce, I.; Deniz, K. Pleomorphic hyalinizing angiectatic tumor in the oral cavity: Report of a rare case. J. Stomatol. Oral Maxillofac. Surg. 2020, 121, 189–191.
  41. Rush, A.J.; Patel, P.D.; Shemesh, S.; Subhawong, T.K.; Pretell-Mazzini, J. Treatment modalities and outcomes of pleomorphic hyalinizing angiectatic tumor: A systematic review of the literature. Musculoskelet. Surg. 2018, 102, 213–221.
More
Information
Subjects: Pathology
Contributor MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to https://encyclopedia.pub/register :
View Times: 432
Revisions: 4 times (View History)
Update Date: 22 Sep 2021
1000/1000